We are live on ! Find out more
FHTX icon

Foghorn Therapeutics
FHTX

105 hedge funds and large institutions have $212M invested in Foghorn Therapeutics in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 9

90% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 21

13% more funds holding

Funds holding: 93 → 105 (+12)

1.66% more ownership

Funds ownership: 74.05% → 75.71% (+1.7%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

6% less capital invested

Capital invested by funds: $226M → $212M (-$13.7M)

Holders
105
Holders Change
+12
Holders Change %
+12.9%
% of All Funds
1.29%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
40
Reduced
21
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DM
Deerfield Management
New York
+$4.09M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.57M
3
BI
BVF Inc
California
+$2.96M
4
CS
Candriam SCA
Luxembourg
+$1.72M
5
WP
Woodline Partners
California
+$872K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$983K
2
Ameriprise
Ameriprise
Minnesota
-$871K
3
Jane Street
Jane Street
New York
-$716K
4
Walleye Capital
Walleye Capital
New York
-$257K
5
Barclays
Barclays
United Kingdom
-$240K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
26
SCS Capital Management
Massachusetts
$511K – – –
Squarepoint
27
Squarepoint
New York
$496K -$208K -37,837 -27%
Charles Schwab
28
Charles Schwab
California
$495K +$116K +21,162 +26%
BGI
29
B Group Inc
Texas
$488K +$560K +102,000 New
Morgan Stanley
30
Morgan Stanley
New York
$471K -$128K -23,251 -19%
Qube Research & Technologies (QRT)
31
Qube Research & Technologies (QRT)
United Kingdom
$389K +$154K +28,021 +53%
DP
32
Diadema Partners
New Jersey
$382K +$271K +49,314 +161%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$380K +$3.63K +661 +0.8%
UBS Group
34
UBS Group
Switzerland
$362K +$282K +51,330 +209%
BCM
35
Bridgeway Capital Management
Texas
$357K – – –
State of Wisconsin Investment Board
36
State of Wisconsin Investment Board
Wisconsin
$314K +$68.6K +12,501 +24%
Bank of America
37
Bank of America
North Carolina
$287K -$75.5K -13,759 -19%
N
38
Nuveen
North Carolina
$241K +$1.34K +245 +0.5%
PAP
39
Persistent Asset Partners
Hong Kong
$223K -$2.55K -464 -1%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$189K -$3.36K -612 -2%
Acadian Asset Management
41
Acadian Asset Management
Massachusetts
$177K +$164K +29,905 +387%
Walleye Capital
42
Walleye Capital
New York
$165K -$257K -46,903 -58%
AQR Capital Management
43
AQR Capital Management
Connecticut
$156K +$104K +19,010 +140%
AllianceBernstein
44
AllianceBernstein
Tennessee
$144K – – –
TI
45
Trexquant Investment
Connecticut
$144K +$165K +30,111 New
Millennium Management
46
Millennium Management
New York
$141K -$983K -179,013 -86%
Point72 Asset Management
47
Point72 Asset Management
Connecticut
$132K -$188K -34,322 -55%
Deutsche Bank
48
Deutsche Bank
Germany
$131K – – –
Canada Pension Plan Investment Board
49
Canada Pension Plan Investment Board
Ontario, Canada
$120K +$67.5K +12,300 +96%
T. Rowe Price Associates
50
T. Rowe Price Associates
Maryland
$118K +$44.3K +8,070 +49%
1
2
3 4 5

FHTX Hedge Fund Activity: Q1 2026 in Review

105 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q1 2026, worth a combined $212M — down 6.1% from $226M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new FHTX positions and 9 closed out — a net gain of 13 holders — while 40 added to existing stakes and 21 trimmed.

The largest buyer was Deerfield Management, adding an estimated $4.09M. The largest seller was Millennium Management, cutting an estimated $983K.

  • 105 institutional investors held Foghorn Therapeutics (FHTX) as of Q1 2026, up from 93 in Q4 2025.
  • Funds reported $212M of Foghorn Therapeutics stock for Q1 2026, down 6.1% quarter-over-quarter.
  • 22 funds opened new Foghorn Therapeutics positions in Q1 2026 and 9 closed out, a net change of +13 holders.
  • The largest Foghorn Therapeutics buyer in Q1 2026 was Deerfield Management, an estimated $4.09M added.
  • The largest Foghorn Therapeutics seller in Q1 2026 was Millennium Management, an estimated $983K sold.

Based on aggregated 13F filings for Q1 2026.